Filtered By:
Specialty: Consumer Health News
Drug: Coumadin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 52 results found since Jan 2013.
Pharmacogenomics in Stroke and Cardiovascular Disease Pharmacogenomics in Stroke and Cardiovascular Disease
This review provides an overview of the genetic variants that influence individual responses to aspirin, clopidogrel, warfarin, and statins and the clinical implications for stroke patients.Stroke
Source: Medscape Today Headlines - January 26, 2023 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Stroke Risk in AF Patients on Rivaroxaban or Warfarin Stroke Risk in AF Patients on Rivaroxaban or Warfarin
This study compared the risk of stroke and all-cause mortality in patients taking rivaroxaban or warfarin for nonvalvular atrial fibrillation.Stroke
Source: Medscape Today Headlines - March 17, 2020 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Comparisons Between OACs Among Older Nonvalvular AF Patients Comparisons Between OACs Among Older Nonvalvular AF Patients
This study compared the risk of stroke and major bleeding with NOACs vs. warfarin among patients 80 years of age and older with nonvalvular atrial fibrillation.Journal of the American Geriatrics Society
Source: Medscape Today Headlines - September 13, 2019 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news
Saving the Brain From Catheter Ablation of AF Saving the Brain From Catheter Ablation of AF
A new study examines when is it appropriate to stop DOACs before catheter ablation of AF. Does discontinuation hold the same peri-procedural risk of stroke as was seen with warfarin discontinuation?European Heart Journal
Source: Medscape Today Headlines - June 26, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Low-Dose Aspirin Linked To Bleeding In The Skull, New Report Says
(CNN) — Taking low-dose aspirin to prevent heart disease and stroke is associated with an increased risk of bleeding in the skull in people without a history of those conditions, according to a new report.
Researchers analyzed data from 13 previous studies in which over 130,000 people ages 42 to 74, who didn’t have a history of heart disease or stroke, were given either aspirin or a placebo for the prevention of these conditions. All the trials reported on the risk of head bleeding.
People who took the placebo had a 0.46% risk of having a head bleed during the combined trial periods. For those who took aspirin,...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 13, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News aspirin CNN Source Type: news
Daily Aspirin No Longer Recommended To Prevent Heart Attacks In Older Adults
(CNN) — If you’re a healthy older adult looking for ways to reduce your risk of heart attack and stroke, don’t turn to that age-old standby: daily low-dose aspirin. It’s no longer recommended as a preventative for older adults who don’t have a high risk or existing heart disease, according to guidelines announced Sunday by the American College of Cardiology and the American Heart Association.
“For the most part, we are now much better at treating risk factors such as hypertension, diabetes and especially high cholesterol,” said North Carolina cardiologist Dr. Kevin Campbell, who wa...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 18, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News aspirin CNN Source Type: news
AF Guideline Update Prefers NOACs to Warfarin in Most Cases AF Guideline Update Prefers NOACs to Warfarin in Most Cases
More nuanced use of stroke-risk scores, percutaneous LAA occlusion, insights into AF complicating ACS, and ascendant non-vitamin-K oral anticoagulants top an AHA/ACC/HRS update to 2014 AF guidelines.Medscape Medical News
Source: Medscape Medical News Headlines - January 31, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news
New blood thinners better than warfarin for atrial fibrillation
(Reuters Health) - Patients with atrial fibrillation, a common heart rhythm disorder, should take newer blood thinners to prevent stroke instead of the old standby drug warfarin, U.S. doctors recommend.
Source: Reuters: Health - January 29, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Higher Incidence of Ischemic Stroke in Patients Taking NOACs Higher Incidence of Ischemic Stroke in Patients Taking NOACs
Does the reduced risk of nontraumatic bleeding in patients taking NOACs as opposed to warfarin come at the cost of a higher risk of ischemic stroke?Stroke
Source: Medscape Today Headlines - December 17, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Cheap drug hope for 500,000 at risk of stroke
HALF a million Britons who are unknowingly at risk of a fatal stroke caused by an irregular heartbeat could be saved by cheap clot-busting drugs, according to research. A study in the European Heart Journal found that 4,000 strokes were prevented in England between 2015 and 2016 among patients with atrial fibrillation , a heart rhythm disorder, by taking anti-coagulants such as warfarin.
Source: Daily Express - Health - July 5, 2018 Category: Consumer Health News Source Type: news
Blood-thinning drugs may reduce dementia risk in people with irregular heartbeats
Conclusion
If you’ve been diagnosed with AF and you have been prescribed anticoagulant treatments such as warfarin or clopidogrel, we already know they protect you against having a stroke. This study suggests they may also help to protect you against dementia.
Cutting the risk of dementia for people who have a raised risk because of AF would be an exciting step forward. Unfortunately, we can’t tell from this study whether the protection against dementia was down to the anticoagulants, because of the possible effect of unmeasured confounding factors.
Usually, we would want to see a randomised controlled trial (RCT) to f...
Source: NHS News Feed - October 25, 2017 Category: Consumer Health News Tags: Neurology Source Type: news
Risk of aspirin-related bleeding is higher in the over-75s
Conclusion
This valuable cohort study helps to quantify the extent of bleeding risk in people taking aspirin for secondary prevention of cardiovascular disease.
Aspirin is well known to carry bleeding risk – particularly in older adults – but this study suggests the risk may be higher than previously thought. The researchers say that for adults under the age of 75, the annual bleeding risk at around 1% is similar to that suggested by previous trials, as is the ratio of bleeds to the number of cardiovascular events. However, this risk increases for older adults, especially for major bleeds of the stomach and upper diges...
Source: NHS News Feed - June 14, 2017 Category: Consumer Health News Tags: Medication Older people Source Type: news
Use of Warfarin in Veterans With AF After Dementia Diagnosis Use of Warfarin in Veterans With AF After Dementia Diagnosis
Should older adults with AF who have been taking warfarin for stroke prevention continue therapy after being diagnosed with dementia?Journal of the American Geriatrics Society
Source: Medscape Today Headlines - March 31, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Fewer Bleeds on Uninterrupted Dabigatran vs Warfarin in AF Ablation Fewer Bleeds on Uninterrupted Dabigatran vs Warfarin in AF Ablation
"Now we have high-quality data showing that if you perform this procedure on uninterrupted dabigatran, the risk of stroke is extremely low," said a researcher about the randomized RE-CIRCUIT trial.Heartwire from Medscape
Source: Medscape Medical News Headlines - March 28, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
Assessing Stroke Risk in Adult Congenital Heart Disease Assessing Stroke Risk in Adult Congenital Heart Disease
Drs Lyle, Ammash, and McLeod discuss risk stratification for stroke in adults with complex congenital heart disease and how to choose between warfarin or the direct oral anticoagulants in the absence of data.Mayo Clinic
Source: Medscape Today Headlines - March 27, 2017 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news
